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1. Introduction 
Microbial symbiosis is an ubiquitous aspect of insect life and plays a fundamental role in the 
adaptation of insects to the most diverse environments. A very large proportion of insects 
are supposed to carry bacterial symbionts (Chaves et al., 2009). The variety of the 
relationships between symbionts and insects are very wide as well as biological function 
exerted by the symbionts and their localisation within the host. In fact, some are located 
within host cells while some others are outside. The genetic modification of microbial 
symbionts has been identified as novel tools to fight insect pests and vectors of infectious 
diseases. In this frame, in the last years, the use of manipulated symbiont has attracted a lot 
of attention for the potential application in the control of mosquito-borne diseases, with 
particular interest to malaria control. 
Malaria still represents a major health problem with particular impact in the developing 
countries. Even though several control tools are employed for malaria control, such as bed 
nets, Anti-malarial drugs, insecticides and other vector control measures, the disease continue 
to exert a dramatic health burden on the world human populations. Consequently, new 
effective tools for malaria control are expected. Human malaria is transmitted by some 
mosquito species belonging to the genus Anopheles and methods aimed to control the malaria 
infection by blocking the transmission from mosquito to humans are particularly attractive. 
Recently, quite a lot of attention has been addressed to the so-called Malaria Symbiotic 
Control (Favia et al., 2008). In fact, more generally, symbiotic microorganisms offer some 
possibilities for insect pest management strategies and two approaches are particular 
attractive: The first one implies the disruption of microbial symbionts required by insect 
pests. The second approach is the manipulation of microorganisms with major impacts on 
insect traits contributing to their “pest status” for example their capacity to act as vector for 
diseases like malaria and others. In particular, the paratransgenic approach looks feasible for 
malaria control.  
Paratransgenesis is the genetic modification of insect symbionts to express anti-pathogen 
molecules within the vector to block pathogen transmission. In case of malaria infection, 
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mosquitoes should be “forced” to host symbionts that have been previously manipulated to 
express effector molecules able to interfere with Plasmodium development, possibly blocking 
transmission.  
In the frame of insect borne diseases, Chagas disease has already proven the feasibility of 
paratransgenesis in the control of the infection. Vectors of Chagas disease are obligate 
haematophagous triatomines that feed on vertebrate blood throughout their entire 
developmental cycle. These insects harbour populations of bacterial symbionts within their 
intestinal tract, which provide nutrients that insects do not acquire by the blood source. 
These symbionts have been isolated, cultured outside the host and genetically transformed 
to express molecules that render the insect refractory to the infection with Trypanosoma cruzi, 
the etiological agent of Chagas disease (Beard et al., 2001). Once reintroduced in the vector 
host, the paratransgenic insect vector showed refractoriness to parasite infection.  
Thus, also on the basis of impulse related to these very exciting results in paratransgenic 
approach to control Chagas disease, since few years, some researches have been addressed 
to the identification microbial symbiont that could be implemented in the development of 
paratransgenic approach for malaria control.  
In this chapter we will give an overview an update of the recent advance in symbiont based-
malaria control. 
2. Best symbiont candidates for malaria control 
For malaria Symbiotic Control (SC), “good” candidates are those microbes residing within 
the mosquito, particularly those localised in the gut. In fact, malarial gametocytes, ingested 
by a feeding mosquito, must transform to gametes, fuse to form zygotes, and then, as 
ookinetes, migrate to the mosquito's midgut epithelium to develop as oocysts that release 
sporozoites to infect the mosquito's salivary glands. At the Oocysts stage of Plasmodium, the 
protozoan parasite causing the malaria infection, represents a favourable target for control 
method like paratransgenesis aimed to interrupt the disease transmission. In fact, in natural 
conditions, from thousands of gametocytes ingested by the mosquito vector in an infected 
blood meal, generally less than ten oocysts will develop. 
As stated above, paratransgensis has been already proposed to control insect borne diseases. 
This is the case of Rhodnius prolixus, a triatomine commonly known as the kissing bug, 
vector of Trypanosoma cruzi the causative agent of the Chagas disease. R. prolixus harbours in 
its gut some bacteria that provide nutrients to the insect. These bacteria have been cultivate 
outside the host, modified to express specific anti-parasite effector molecules and 
reintroduced within the vector (Beard et al., 2001). These paratransgenic insects have shown 
to be unable to transmit the parasite. These evidences have posed the basis for the 
development of paratransgenic-related strategies, based on gut symbionts, to control insect 
borne diseases.  
In the meanwhile they represent the cornerstone on which to base the development of SC of 
malaria infection.  
The search of gut symbiont has been primarily addressed to the identification of bacteria 
residing in the mosquito gut. Some studies have described the structure of the bacterial 
community present in several mosquito species (Demaio et al., 1996; Pidiyar et al., 2002, 
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2004; Touré et al., 2000), pinpointing that different mosquito species harbour common 
bacterial genera (e.g. Pseudomonas, Staphylococcus, Enterobacter, Escherichia), some of which 
might be cultivated outside the vector and manipulated by the means of genetic tools that 
are already available.  
Cultivability in cell-free media and applicability to genetic transformation are two of the 
fundamental prerequisite of a “good” symbiont to be applied in paratransgenesis control of 
insect vectors.  
More recently, the application of advanced molecular techniques, led to the identification of 
bacterial species, never described before, has stable component of the microbiota associated 
to malaria vectors.  
For example in the African malaria vector Anopheles arabiensis two new species have been 
recently described (Kämpfer et al., 2006a, 2006b). One was named Janibacter anophelis the 
other Thorsellia anophelis to remark the close relationship with the mosquito host. In 
particular, T. anophelis has been proposed in malaria paratransgenic control, since this 
bacterium, by the means of sequencing of major bands generated in Denaturing Gradient 
Gel Electrophoresis (DGGE) experiments, appears to be dominant in Kenyan populations of 
Anopheles gambiae, the main African malaria vector (Briones et al., 2008) and dominance is 
indeed one additional main features required for a symbiont to be employed in 
paratransgenesis.  
The list of bacteria well adapted to malaria vectors midgut has been rapidly growing in the 
last few years. Among these bacteria two species have been recently described as particularly 
well adapted to An. gambiae midgut, Pantoea stewartii and Elizabethkingia meningoseptica (Lindh 
et al., 2008) and thus potentially useful for symbiotic control applications.  
Recently, we have identified a Gram-negative -proteobacteria as stably associated to 
different mosquito species with particular regards to some main malaria vector species 
(Favia et al., 2007, 2008; Damiani et al., 2008, 2010; Crotti et al., 2009) and its further 
microbiological and molecular characterization clearly indicate it as belonging to the genus 
Asaia (Ricci et al. 2011a).  
The relationship between Asaia and mosquito is particularly intriguing in the view of 
paratransgenic applications since this bacterium localizes in the gut (Figure 1), in the 
salivary glands and in the reproductive organs of both male and female adult mosquitoes. 
These localizations are important since in the mosquito gut and salivary glands overlaps 
with that of Plasmodium thus supporting the use of Asaia for paratransgenic applications. 
The localization in the reproductive organs relates to vertical transmission routes that imply 
favourable means to introduce modified bacteria in the field (Damiani et al., 2010). 
Furthermore, Asaia is easily cultivable in cell-free media, is detectable at all developmental 
stage of the mosquito and has high prevalence in mosquito populations. These 
characteristics have indicated Asaia as one of the potentially best bacterial symbiont of 
malaria vectors to develop paratransgenic protocols to control malaria infection. 
Transformation of Asaia was originally achieved by a strain originally isolated from 
Anopheles stephensi, one of the major Asian malaria vector, and was attempted by using 
different plasmid vectors. 
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Among these, the plasmid pHM2 was the most efficient and transformed Asaia with high 
efficiency. The gene cassette coding for the green fluorescent protein (Gfp) was cloned into the 
plasmid vector pHM2 thus providing an efficiently detectable marker to trace mosquito body 
colonization. Transformed Asaia cells were found to efficiently express the protein and showed 
bright fluorescence useful for localization of the symbiotic cells in the insect body detectable by 
fluorescent confocal laser scanning microscopy (Figures 2 and 3). Furthermore, in laboratory, 
when we proposed fed mosquitoes by cotton pad soaked in a mixture of sugar and “green” 
bacteria, nearly 100% of the recipient populations resulted colonised by the modified Asaia.  
 
Fig. 1. Asaia bacteria in the gut of an adult An. stephensi mosquito. 
 
Fig. 2. Asaia strain expressing the green fluorescent protein in the midgut of an Anopheles 
stephensi female specimen.  
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Fig. 3. Asaia strain expressing the green fluorescent protein in the midgut of an An. stephensi 
male specimen. 
2.1 Effector molecules with anti-Plasmodium effects 
Some molecules have proven to be effective in inhibiting the development of the malaria 
parasite within the mosquito vector and may be implemented in paratransgenic 
experiments aimed to block malaria transmission.  
Among them has to be mentioned the small dodecapeptide SM1. This peptide is able to 
interfere with a binding protein of the lumen of the mosquito midgut and salivary glands 
that is required for Plasmodium invasion. This interference between SM1 and mosquito 
midgut results in the inhibition of parasite development (Ghosh et al., 2001). A second 
molecule to be mentioned is the snake venom phospholipase named PLA2 that is able to 
block Plasmodium development within the mosquito by the inhibition of the association 
between ookinetes and midgut surface (Zieler et al., 2001).  
A third molecule is Scorpine an antimicrobial peptide isolated from the venom of the 
scorpion Pandinus imperator, with anti-bacterial activity and a potent inhibitory effect on the 
ookinete and gamete stages of the rodent malaria parasite Plasmodium berghei development 
(Conde et al., 2000).  
Other effector molecules to be mentioned are two single chain antibodies called anti-
PfNPNA1 and anti-Pbs 21 respectively. 
The single-chain antibody PfNPNA-1 is based on a recombinant human monoclonal 
antibody that specifically recognizes the repeat region (Asn-Pro-Asn-Ala) of the Plasmodium 
falciparum surface circumsporozoite protein and agglutinates sporozoites (Chappel et al., 
2004). 
Pbs21 is an ookinete surface protein of P. berghei, a rodent’s parasite, belonging to a class of 
sexual stage antigens able to induce in the vertebrate host a transmission-blocking immune 
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response. The effectors of this transmission-blocking immunity are antibody molecules 
directed against particular protein epitopes (Spano et al., 1996). Anti-Pbs 21 may be used in 
paratransgenic experiment in the murine system to prove the feasibility of the approach. 
Some studies have already shown the possibility to use mosquito guts bacteria to deliver 
anti-Plasmodium effector molecules within the mosquito vector (Riehle and Jacobs-Lorena 
2005; Riehle et al., 2007).  
In these studies are reported that E. coli bacteria expressing SM1 and PLA2, are able to 
partially inhibit the parasite development. Very recently, Bisi & Lampe (2011) described 
Pantoea agglomerans engineered to express and secrete anti-Plasmodium effector proteins. To 
this purpose, plasmids that included the pelB or hlyA secretion signals from the genes of 
related species were constructed and tested for their efficacy in secreting SM1, anti-Pbs21, 
and PLA2 in P. agglomerans and E. coli.  
Very interestingly, P. agglomerans was able to secrete HlyA fusions of anti-Pbs21 and PLA2, 
and now ongoing experiments are evaluating these strains for anti-Plasmodium activity in 
infected mosquitoes.  
It is worth to remind that parasites tend to have a heterogeneous genome that favours 
selection of individuals able to overcome barriers such as drugs or possibly effector gene 
products favouring the insurgence of resistant strains. Thus the possibility to release 
paratrasgenic mosquito carrying microbial symbionts modified to express several different 
molecules would circumvent the selection of resistant malaria strains.  
The results cited above, represent a clear “proof of principle” about the applicability of 
paratransgenesis in malaria control. 
In this context, the symbiotic bacterium Asaia previously described, may be very 
successfully implied.  
We engineered Asaia strains that were transformed to produce fluorescent proteins; they 
showed a remarkable capacity to colonize the midgut, reproductive organs ad salivary 
glands of recipient mosquitoes (Favia et al., 2007; Damiani et al., 2008, 2010). These studies 
underline the possibility of using this bacterium to express anti-parasite molecules within 
the mosquito body, to inhibit the transmission of the parasite.  
Furthermore, Asaia can be transmitted, vertically to the progeny (by maternal, paternal and 
trans-stadial routes) and horizontally between mosquito individuals by mating and co-
feeding (Favia et al., 2007, 2008; Damiani et al., 2008, 2010).  
As stated above, vertical transmission is important because it offers the chance of 
introducing engineered bacteria into mosquito populations in the field. In An. gambiae it has 
been proven that vertical transmission occurs by an egg-smearing mechanism, where the 
extracellular Asaia symbionts are smeared onto the egg surface, thus is quite likely that 
larvae, after emergence, are infected by the bacteria by feeding on them and on egg 
remnants (Damiani et al., 2010).  
Larvae infection by bacteria in the breeding water, offers a way to spread recombinant 
bacteria in the field, moreover the vertical transmission of Asaia symbiont would allow the 
“passage” of recombinant symbionts through the generations. 
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Paternal transmission is also important because offers an alternative way to release 
engineered bacteria in the field in addition to their release in the larval breeding site to 
contaminate larvae and consequently adults by trans-stadial routes. Indeed, paternal 
transmission suggests the possibility of releasing not biting male mosquitoes that would be 
previously colonised with engineered bacteria (Damiani et al., 2010).  
Ongoing studies are intended to modify Asaia to produce strains able to express and secrete 
anti-Plasmodium effector molecules and to test their ability in blocking malaria transmission. 
2.1.1 Not only bacteria 
It is worth to mention that not only bacteria symbiont may find application in 
paratransgenesis but several evidences indicate that virus, yeast and fungi may also be 
successfully use. 
Ren and collaborators (2008) discovered, cloned and characterized the first known DNV 
(AgDNV) capable of infection and dissemination in An. gambiae. By the development of an 
AgDNV-based expression vector to express gene(s) of interest in An. gambiae, an exogenous 
gene (enhanced green fluorescent protein; EGFP) was expressed in An. gambiae mosquitoes. 
Wild-type and EGFP-transducing AgDNV virions were able to consistently infect An. 
gambiae larvae, expressed EGFP was detected in adult tissues such as midgut, fat body and 
ovaries and were transmitted to subsequent mosquito generations.  
This work produced clear evidence that AgDNV could be used as part of a paratransgenic 
malaria control strategy by transduction of anti-Plasmodium effectors or insect-specific toxins 
in Anopheles mosquitoes.  
In the last few months we have identified the yeast Wickerhamomyces anomalus as stably 
associated to some malaria vector species localising at the level of midgut and reproductive 
organs of the host (Ricci et al., 2011b, 2011c). This localization, the possibility to easily 
manipulate yeast and the chance to express effector molecules in a eukaryotic organism 
render W. anomalus a potential good candidate for paratransgenesis. Interestingly, very often 
we found in the midgut and reproductive organs of the mosquito a large number of Asaia 
bacteria in association with a relevant number of W. anomalus. This finding may support the 
idea to use synergistically these two symbionts to release different effector molecules in the 
mosquito.  
We are now proceeding to achieve rapidly a stable transformation system to produce strains 
of W. anomalus able to express and delivery anti-Plasmodium peptides. 
Very recently, Fang et al (2011) develop transgenic fungi that kill malaria parasite in the 
mosquito. 
They used the fungus Metarhizium anisopliae to infect mosquitoes through the cuticle. 
Recombinant strains of M. anisopliae expressing three effector molecules (SM1, a single chain 
antibody called PfNPNA-1 and an antimicrobial peptide called scorpine) targeting 
sporozoites during their travel through the hemolymph to the salivary glands were used to 
infect mosquitoes that had a Plasmodium-infected blood meal eleven days before.  
The reduction in sporozoite counts was relevant and even more when using M. anisopliae 
strain expressing scorpine and an [SM1](8): scorpine fusion protein (with the reduction in 
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sporozoite counts of 98%). These experiments prove that Metarhizium-mediated inhibition of 
Plasmodium development could be an additional tool to contrast malaria development 
within the vector. 
2.1.2 Not only paratransgenesis 
Symbiont may be successfully implied in SC of mosquito vector even without their genetic 
manipulation. This would be the case of W. anomalus. In fact several strains of this yeast 
produce killer toxins with an antimicrobial effect on a wide spectrum of human pathogens 
(Séguy et al., 1998; Magliani et al., 2001), including insect-transmitted protozoan parasites 
such as Leishmania spp. (Savoia et al., 2002). Preliminary data seems to confirm that the W. 
anomalus strain isolated from An. stephensi, produces a killer toxin that is active against some 
yeast strains (Ricci et al. manuscript in preparation). We will soon test if this killer toxin is 
active against Plasmodium to verify the possibility to contrast malaria parasite development 
by the release of this natural killer within mosquito organs. 
One mosquito symbiont that has been extensively studied is the alpha-proteobacterium 
Wolbachia, a very common cytoplasmic symbiont of the majority of insect species, 
crustaceans, mites, and filarial nematodes (Serbus et al., 2008). Wolbachia are maternally 
inherited bacteria that inducing cytoplasmic incompatibility in mosquitoes that they use to 
spread themselves through populations enhancing their transmission (Sinkins, 2004). This 
ability of self-spreading through mosquito populations attracted a lot of attention in the last 
few years and has been proposed as a gene drive system for mosquito genetic replacement, 
for the reduction of population size or for modulating population age structure to reduce 
disease transmission. 
Interestingly, even though the very wide range of insect species naturally infected by 
Wolbachia, natural infection has never been detected in species belonging to the genus 
Anopheles (Ricci et al., 2002; Rasgon & Scott, 2004; Tiawsirisup et al., 2008). On the other 
hand cultured Anopheles cells can be infected (Jin et al., 2009), this has opened new 
possibility to study perspectives in the use of endosymbiont to control malaria infection. 
An “over-replicating” strain of Wolbachia pipientis named wMelPop has recently been shown to 
induce immune upregulation and inhibition of pathogen transmission in Aedes aegypti the 
principal mosquito vector of dengue viruses, thus transient somatic infections of wMelPop 
were performed by intrathoracic inoculation in An. gambiae. As consequence of these 
inoculations, up-regulation of several specific immune genes was detected and some of these 
have shown a direct influence on the development of malaria parasites. Similar results have 
been achieved when using a stably infected An. gambiae cell line (Kambris et al., 2010). 
Other studies have characterized somatic infections of two diverse Wolbachia strains 
(wMelPop and wAlbB) in An. gambiae. After infection, wMelPop was localized in fat body, 
head, sensory organs and other tissues but was not detected in midgut and ovaries, even 
though both Wolbachia strains inhibit P. falciparum oocyst in the mosquito midgut.  
Even more interestingly, although not virulent in non-bloodfed mosquitoes, wMelPop was 
found to be virulent for around 12-24 hours post-bloodmeal. All these data strongly indicate 
that if stable transinfections would behave similarly to somatic infections, Wolbachia could 
potentially be used as part of a strategy to control malaria-transmitting mosquitoes (Hughes 
et al., 2010).  
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From this point of view, the “Ae. aegypti lesson”, can be particularly important. Similar to 
Anopheles, Ae. aegypti has never been detected as naturally infected by Wolbachia, trans-
infection of selected strains of Wolbachia in Ae. aegypti can block the development of dengue 
infection (Walker et al., 2011).  
Very recently the wMel Wolbachia strain was introduced into Ae. aegypti from Drosophila 
melanogaster showing a successfully invasion two natural Ae. aegypti populations in 
Australia, reaching almost the fixation in a few months after the releases of wMel-infected 
An. aegypti adults (Hoffmann et al., 2011).  
These findings demonstrate that Wolbachia-based strategies can be a successful approach to 
eliminate dengue infection and a similar approach may be developed to control malaria 
infection. 
3. Future development and conclusion 
The concept that manipulation of microbial symbionts may represent an important tool to 
contrast insect pests and insect vectors of infectious diseases is now widely accepted. 
Recent studies have also pointed out that is possible to overcome many of the limitations 
that since some time ago represented strong limitation to this approach, including the 
difficulty to culture and transform many symbionts. As discussed in the previous 
paragraph, to date several symbionts of insect pests and vector borne diseases can be 
cultivated outside the host, manipulated to express specific factors and reintroduced within 
the host to produce in situ the effector molecules. A very informative example of advanced 
studies in genetic manipulation of insect symbionts is Rhodococcus rhodnii, a bacterial 
symbiont of the reduviid bug Rhodnius prolixus. This bacterium, if manipulated 
appropriately, can be reintroduced to the vector and inhibit the transmission of Trypanosoma 
cruzi that causes Chagas disease (Beard et al., 2001). Another example regards the bacterium 
Alcaligenes, a gut symbiont of the sharpshooter Homalodisca coagulata, the vector of Pierce’s 
crop disease (Bextine et al., 2004).  
Concerning malaria control, we have described some symbionts that can be cultured outside 
the mosquito and can be genetically modified to produce specific molecules that have 
proven to have an inhibitory effect on Plasmodium development. In the last 5 years our 
group has been focused in the study of symbiosis in mosquito vector. Our group as well as 
others research units, have indicated few microorganisms that possess a strong potential in 
the paratransgenic control of mosquito-borne diseases and in the very few last years, the 
number of parasite of medical and veterinary for which the paratransgenic approach has 
been proposed as one of the element of an integrated control strategy is increasing as 
demonstrated by study aimed to develop control method of Leishmania parasite (Hurwitz et 
al., 2011). However, even if the genetic modification of insect symbionts to inhibit parasite 
development, is clearly feasible and achievable in laboratories, many concerns need to be 
properly addressed before this approach can be applicable in the field. Even though the 
release of paratransgenic mosquito poses much less ethical and safety concerns that the 
release of genetically modified mosquitoes, for example the release of large-scale transgenic 
mosquitoes, would cause not only an increase of the nuisance but also the health risk related 
to other mosquito borne diseases (it is worth to remind that malaria vector mosquitoes may 
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transmit other pathogens), the release into the field of modified symbionts needs to be 
approached with caution since particularly bacteria may spread very rapidly by horizontal 
transfer and colonize non target organisms with still unknown consequence. On the other 
hand is possible to argue that there is no reason to believe that any of the effector molecules 
identified to date will have any effects on non-target organisms (especially higher 
organisms) being specifically intended against Plasmodium. Still, it is necessary the release of 
paratransgenic mosquitoes must refer to previous experiences with different Genetically 
Modified Organisms (GMO) (i.e. GM plants) taking into account indications from different 
national and international authorities that have already established legal requirements for 
the safety of these products (Aguilera et al., 2011). 
If scientific and ethical concerns have to be properly addressed it is also equally important to 
address concerns of public perception. First of all it is important to underline that no single 
approach can be successfully per se but only an integrated control program that will merge 
the benefits of different type of approaches would be effective in controlling malaria 
infection. This is true also for the paratransgenic approach. 
It is important to involve residents of the malaria affected countries and their government in 
official way. In this context it is particularly important to widely release the results of safety 
tests regarding the use of paratransgenic mosquitoes without covering any possible risk 
associated to the use of such an approach pinpointing precisely the “real balance” between 
potential benefits and risks associated to the implementation of the paratransgenic strategy. 
Christopher Boete (2011) has just published the results of an important study about the use 
of transgenic mosquitoes as a potential approach to interrupt malaria transmission. 
This study was performed through a questionnaire addressing questions related to the type 
of research, the location, the nationality and the perception of the public involvement by 
scientists. The results indicate that even if malaria researchers agree to interact with a non-
scientific audience pinpointing that “they remain quite reluctant to have their research project 
submitted in a jargon-free version to the evaluation and the prior-agreement by a group of non-
specialists”. The study shows the importance of fostering structures and processes that could 
lead to an improved involvement of an unspecialized public in the debates linking scientific, 
technological and public health issues in Africa. 
One more aspect that is very important to guarantee success to the paratransgenic approach 
is the capacity to integrate laboratory and field work bringing together competences from 
different disciplines and context to produce a variegate and efficient bulk of skills that will 
be more effective that the simple sum of independent competences. 
Before any possible field applications, the next step in the assessment of the paratransgenic 
approach will take advantage by the so-called “semi-field” studies. They can be conducted 
in mosquito-proof greenhouses that have been termed “malaria spheres” by Knols and 
collaborators (2002). The green-houses consist in a space-limited ecosystem that recreates an 
ecological contest with plants, breeding sites etc in which is possible to perform the tests. 
These test will give important insights about the dynamic of transmission of a due 
symbiont, in fact releasing subsequent different small numbers of paratransgenic 
mosquitoes into a malaria sphere containing non-paratransgenic mosquito population it will 
be possible to determine to the minimum proportion of paratatransgenic insects that need to 
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be introduced for the symbiont to spread over the whole population. Furthermore it will be 
possible to acquire information about the capacity of modified symbiont(s) to compete with 
the natural microbiota. Moreover, all the data acquired by semi-field studies would also 
provide valuable parameters for modelling experiments to assess the feasibility of 
introducing GM-symbionts under true field conditions. 
Even though laboratory and field issues have still to be fully overcame, the fast and growing 
progress recently made in the field of the SC of insect pest and vectors of diseases, induces a 
relevant optimism that this approach may be applicable for field testing within the next 
decade thus offering a new weapon to the arsenal against malaria infection.  
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